相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Gap junctional channels are parts of multiprotein complexes
Jean-Claude Herve et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2012)
Prediction of Response to Neoadjuvant Chemotherapy: New Biomarker Approaches and Concepts
Carsten Denkert et al.
BREAST CARE (2011)
Validation of a Novel Staging System for Disease-Specific Survival in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy
Elizabeth A. Mittendorf et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Pathologic Complete Response After Neoadjuvant Chemotherapy Plus Trastuzumab Predicts Favorable Survival in Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer: Results From the TECHNO Trial of the AGO and GBG Study Groups
Michael Untch et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Pathological complete response and survival according to the level of HER-2 amplification after trastuzumab-based neoadjuvant therapy for breast cancer
S. Guiu et al.
BRITISH JOURNAL OF CANCER (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Connexin 26 expression correlates with less aggressive phenotype of intestinal type-gastric carcinomas
Xiaoli Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2010)
Common and discriminative clinicopathological features between breast cancers with pathological complete response or progressive disease in response to neoadjuvant chemotherapy
Tomo Osako et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Clinical significance of the expression of connexin26 in colorectal cancer
Shinya Nomura et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Prognostic Value of Estrogen Receptor and Ki-67 Index after Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Expressing High Levels of Proliferation at Diagnosis
L. Miglietta et al.
ONCOLOGY (2010)
Gap Junctions and Cancer: New Functions for an Old Story
Laurent Cronier et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Comparison among different classification systems regarding the pathological response of preoperative chemotherapy in relation to the long-term outcome
Tadahiko Shien et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Connexin43 pseudogene in breast cancer cells offers a novel therapeutic target
Andrew Bier et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Gap Junctions
Daniel A. Goodenough et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy
Silvia Darb-Esfahani et al.
BREAST CANCER RESEARCH (2009)
Staging of breast cancer in the neoadjuvant setting
Jacqueline S. Jeruss et al.
CANCER RESEARCH (2008)
Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy
Jacqueline S. Jeruss et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts
Jean-Philippe Theurillat et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
The stage-specific function of gap junctions during tumourigenesis
Jaroslaw Czyz
CELLULAR & MOLECULAR BIOLOGY LETTERS (2008)
Predictive markers in breast cancer - the present
S. J. L. Payne et al.
HISTOPATHOLOGY (2008)
Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast
Gunter von Minckwitz et al.
BREAST CANCER RESEARCH (2008)
Tissue microarray analysis of connexin expression and its prognostic significance in human breast cancer
Chris Conklin et al.
CANCER LETTERS (2007)
Connexins and gap junctions in mammary gland development and breast cancer progression
Elizabeth McLachlan et al.
JOURNAL OF MEMBRANE BIOLOGY (2007)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Connexins as precocious markers and molecular targets for chemical and pharmacological agents in carcinogenesis
G. Pointis et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Connexins and their channels in cell growth and cell death
M Vinken et al.
CELLULAR SIGNALLING (2006)
Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer
L Kanczuga-Koda et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Changes in gap junctional connexin isoforms during prostate cancer progression
AW Tate et al.
PROSTATE (2006)
Gap junctions and the propagation of cell survival and cell death signals
DV Krysko et al.
APOPTOSIS (2005)
Stability of the HER2 gene after primary chemotherapy in advanced breast cancer
Z Varga et al.
VIRCHOWS ARCHIV (2005)
Role of gap junctions during early embryo development
FD Houghton
REPRODUCTION (2005)
Gap junctions and the connexin protein family
G Söhl et al.
CARDIOVASCULAR RESEARCH (2004)
Negative regulation of p21 by β-catenin/TCF signaling:: a novel mechanism by which cell adhesion molecules regulate cell proliferation
J Kamei et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Gap junction intercellular communication during lymphocyte transendothelial migration
E Oviedo-Orta et al.
CELL BIOLOGY INTERNATIONAL (2002)
分享论文
